School Of Medicine

The Vanderbilt Kennedy Center has announced its latest Nicholas Hobbs Discovery Awards, which recognize innovative research to improve the lives of people with intellectual and developmental disabilities. Colleen Niswender, Dr. Bill Nobis, Audrey Bowden and Laurie Cutting are the recipients for 2025–26, earning support for projects that address Rett syndrome, Dravet syndrome and other developmental epilepsies, and reading difficulties like dyslexia. Read More

A new potential treatment for schizophrenia discovered through the Warren Center for Neuroscience Drug Discovery has entered phase 1 clinical trials, marking the fifth WCNDD therapeutic to advance into human testing. Read More

Schizophrenia has been proven to be heritable, but typical analyses so far haven’t been able to pinpoint what, genetically, is going wrong in the brain. A new paper by Professor Bingshan Li and research instructor Rui Chen outlines how to improve on existing genetic screening for schizophrenia risk by expanding the areas of the chromosome scanned for genetic signals. Their results point to a “tangible biological pathway—and potential treatment target—linking genetic risk to the pathogenesis of schizophrenia,” Chen said. Read More

Shan Meltzer has been awarded a prestigious Edward Mallinckrodt, Jr. Foundation Award to advance her pioneering research that seeks to determine how the body’s sensory circuits form and function. Her work seeks to answer a fundamental question in neuroscience: how do the brain and spinal cord organize their intricate networks to perform such a wide range of functions? Read More

At Vanderbilt, research doesn’t just live in the lab. It moves into the world in the shape of new tools, treatments and technologies that improve lives, support communities and expand what’s possible. Read More

Five exceptional Vanderbilt faculty members have been named 2025 Master Innovators for their extraordinary contributions to translating research into commercial applications that have significant societal impact. The 2025 honorees represent diverse fields from infectious disease therapeutics to neuroscience drug discovery and biomedical engineering.  Read More

The AAVA embodies the transformative power of connection and cultural identity—all from a place of gratitude. It strengthens the presence of the Asian Pacific Islander Desi American community through cultural celebrations and networking events, collaborating with student organizations to connect alumni with current Vanderbilt students. Joy Cox, BA’98, MD’02, is AAVA's president. Read More

Miller Morris, BS’16, MS’17, MPH’19, is the founder and CEO of Comma, a company that aims to improve reproductive health through menstrual care products, sustainability, clinical research and technology. She describes herself as a “women’s health researcher turned social entrepreneur.” Read More

The role of artificial intelligence in drug discovery has been limited by machine learning methods that fail when they encounter chemical structures they weren’t “trained” on. Assistant Professor Benjamin Brown has written a paper suggesting a more targeted approach: using a task-specific model architecture that’s intentionally restricted to learn from a representation of the interaction space between a protein and a drug molecule and be better able to generalize and figure out which compound might best interact with that protein. That’s important, because identifying those compounds early cuts the costs and time involved in developing drugs. Read More

Advanced melanoma can be notoriously resistant to standard immunotherapy, but a new drug combination might hold some hope for patients with this most common form of skin cancer. Professor Emerita of Pharmacology Ann Richmond and her team, in preclinical work, created a “tumor microenvironment more receptive to immune challenge.” The treatment slowed tumor growth, showed stronger immune responses and increased helpful T cells. It could be on a faster-than-typical track to human studies because all the drugs are already involved in other clinical trials. Read More

Three leaders in health policy, informatics and cancer research from Vanderbilt University Medical Center have been elected this year to membership in the National Academy of Medicine, a preeminent advisory body on critical matters of health care, medicine and public health. Read More

Vanderbilt University announced nine recipients of the Innovation Catalyst Fund awards for the June 2025 cycle, continuing its mission of accelerating translational research and driving innovative solutions to real-world challenges by providing faculty with crucial pre-seed funding across diverse disciplines.  The newly selected projects span cutting-edge work in health care, engineering and technology solutions. Read More

Stata and R boot camps are coming up this fall for those seeking a refresher in the basics. These interactive, hands-on sessions provide guided practice using the software and include an optional hour after each class for individual questions with the instructor. Read More

Kathleen DelGiorno, assistant professor of cell and developmental biology, has received a Research Scholar Award from the American Cancer Society. The award will fund research into potential therapies against pancreatic cancer, the third-leading cause of cancer-related deaths in the United States, which is forecast to become the second-leading cause by 2030. Read More

Three Vanderbilt faculty members are diving into a "chicken-and-egg" problem of type 2 diabetes: Does the disease change beta-cell subtypes? Or do changes in the cells cause diabetes? Guoqiang Gu, Emily Hodges and Ken Lau have come up with a new method of studying the subtypes that can track them through different stages instead of just once when they're fully developed. "Thanks to this and other research, it may be possible to one day create a diet supplement for pregnancy that could reduce the risk of diabetes for babies," Gu said. Read More

After concluding her term as associate dean for academic affairs for the Graduate School, Terrah Akard will return to her role as professor of nursing in the School of Nursing. Julián Hillyer, Centennial Professor of Biological Sciences, and Andrea Page-McCaw, Stevenson Chair and professor of cell and developmental biology, have been named associate deans for academic affairs. Read More

Five Vanderbilt researchers have received Seeding Success grants for early-stage projects that have strong potential for external funding. The program, managed by Research Development and Support, reflects the university’s commitment to advancing high-impact research across disciplines. Read More

In a scientific first, researchers from Vanderbilt University and the University of California, San Diego, have generated a high-resolution metabolic “map” of how cells orchestrate glucose processing, revealing a hidden world where organelles and molecular complexes collaborate when responding to a rush of nutrients. This new study, published in Nature Communications, has redefined how glucose metabolism is visualized at the single-cell level. Read More

A collaboration among VUMC, the College of Arts and Science, the School of Medicine and the School of Engineering has led to some higher-order “hitchhikers” that can make immunotherapy cancer treatments more effective. Associate Professor John Wilson’s lab devised a way to piggyback cancer-fighting nanobodies onto molecules that naturally accumulate around tumors—getting the treatment where it needs to go. Read More

Quynh Anh Nguyen, assistant professor of pharmacology, is the first Vanderbilt faculty member to be awarded the highly competitive Klingenstein Fellowship in Neuroscience since 1985. Her research aims to unravel the mysteries of epilepsy by focusing on how specific cells in the brain contribute to or suppress the hyperexcitability in neural circuits that are thought to be involved in the disorder’s spontaneous seizures. Read More